1. Pharma giants ditch Twitter after fake Eli Lilly tweet Full story

2. FDA approves most expensive drug on market Full story

3. Mark Cuban Cost Plus Drugs adds 82 drugs to portfolio Full story

4. Biosimilar competition is driving down drug costs. Healthcare leaders can sustain the momentum with key takeaways from this discussion.

5. 10 systems seeking pharmacy leaders Full story

6. Attorneys for fired MetroHealth CEO allege board retaliation Full story

7. 61% of systems plan to expand telehealth — see how and in what areas here.

8. Despite high demand, Tamiflu drugmaker says it's on track with supply Full story

9. Stanford researchers to test Paxlovid as a long COVID-19 treatment Full story

10. Inflation Reduction Act will restrict oncology drug development, Bristol-Myers Squibb CEO says Full story

11. Health systems are finally getting ahead of inefficiencies. Here's how SSM Health solved uneven patient loads & workload imbalances.

12. Merck to scoop Imago BioSciences for $1.35B Full story

Becker's Learning Opportunities

1. Spine surgeons want better performing interbody cages. A new porous PEEK technology will become the gold standard. See this white paper with key findings from in-vitro and in-vivo studies.

2. Achieving sepsis quality improvements shouldn't take long. This hospital saved $384,000K + boosted compliance by 20% in just 4 months. Here's how.

3. OR closures will cost hospitals billions in 2022 — Hospitals must do more with less. Here's how 3 hospitals achieved greater efficiency in the OR with fewer surgical staff.